-
Reagent Search
-
Antibodies Recombinant antibodies, monoclonal & polyclonal antibodies and primary & secondary antibodies.
-
Biochemicals Carbohydrates, peptides, bioactive small molecules, buffers, dyes and lipids.
-
Cell Lines & Models Cell lines, tissues, bacteria & viruses, and animal models.
-
Kits & Assays ELISA kits, multiplex immunoassay kits, detection/staining kits and conjugation/labelling kits.
-
Nucleotides Plasmids, primers, RNA, siRNA, shRNA, gRNA, viral vectors and particles.
-
Proteins Enzymes, growth factors, binding proteins like streptavidin and protein mixtures like bovine serum.
-
- Toolbox
-
Custom Suppliers
-
Antibody Suppliers Polyclonal, monoclonal, recombinant or alternative affinity reagent production.
-
Cell line Suppliers Knockout cell lines, knockin cell lines, gene activation & repression and reporter cell lines.
-
Histology Suppliers Immunohistochemistry (IHC), in situ hybridisation (ISH), tissue microarray staining (TMA), and more.
-
Peptides Suppliers Standard and modified sequences, fluorescent, isotope and radioactive labelled peptides, and more.
-
Sequencing Suppliers Whole Genome Sequencing, Antibody Sequencing, Targeted Sequencing, and more.
-
- CiteAb Unlimited
CiteAb: Our story
About CiteAb
CiteAb provides world-class data that accelerates scientific research by powering a search engine for researchers and data services for reagent suppliers, finance companies, publishers, biotech/biopharma companies and specialist partners.
CiteAb: Reagent Search & Data Services
The CiteAb Story
CiteAb has grown from an academic project to an innovative data company that serves hundreds of thousands of researchers and many of the world's leading reagent suppliers and financial companies.
-
Research project
We started life in 2012 as a research project led by Dr Andrew Chalmers at the University of Bath, in partnership with technology company Storm. It’s aim was to provide a proven route to sourcing antibodies that actually work through the application of technology to identify those products that had been cited in the scientific literature.
-
Spin out
After the research project concluded with huge success, with a rapidly growing user base of researchers, a move was made to spin the research out of the University in 2014 and create a commercial entity to better serve researchers and a fledgeling client base. CiteAb was born.
-
Biggest antibody search engine
Over the following 18 months, CiteAb grew to become the world’s largest Antibody Search Engine, serving tens of thousands of researchers each month. A host of new data was added to provide more information about the antibodies and the experiments they were used for.
-
Data services
Alongside the meteoric rise in popularity seen by the Search Engine, CiteAb had by now developed a world leading data services arm by repurposing data that was used to power the search. This data proved so powerful, and of such high quality, that CiteAb’s client list rapidly grew.
-
Multiple reagents
As both the commercial and research client base continued to rapidly expand, CiteAb redoubled it’s efforts to focus on data quality. CiteAb responded to researcher and supplier feedback by starting to collect data on other reagent types, with the first update in 2018 including the addition of biochemicals, kits and proteins, and the next update in 2020 including experimental models.
-
Published images
Alongside a growing data portfolio, CiteAb expanded its product offering into published images in 2019. Manually cropping each image ensured maximum value for researchers and suppliers and maintained CiteAb’s high standards for quality. As well as images, the ability to create an account was added, enhancing the experiences of CiteAb’s users.
-
Future of CiteAb
CiteAb will continue to focus on producing high quality data that provides insight to researchers, suppliers and financial organisations. Our data type coverage will continue to expand across reagent types, but also into fields such as instruments and software. We’ll remain focused on making our data as powerful and easy to use as possible for our researchers and commercial clients.